2024-06-30 12:59:39 pm | Source: Sushil Financial
BUY VENUS REMEDIES LTD. For Target Rs. 388 - Sushil Financial
We had re-instated coverage on Venus Remedies Ltd. with a BUY rating on March 28, 2024 at Rs.310 for a target price of Rs.388 With the recent run-up in the share price, we change the rating to neutral and close our coverage on the company. At the day’s high of Rs.384, the stock has generated ~24% returns from our recommendation.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Company Update : Rural Electrification Corporation L...
Centre disbursed Rs 964 crore to electronics sector ...
Krystal Integrated Services delivers strong financia...
Zupee Brings Salman Khan`s Signature Quirk to Its Ne...
Company Update : Bajaj Finance By Motilal Oswal Fina...
Centre notifies new Income-Tax Rules for non-residen...
Gold Advances to $2,750 Amid Trade Uncertainty and R...
Temperature Rise in North Won't Affect Rabi Crops by...
Company Update : HDFC Bank By Motilal Oswal Financia...
Pre budget Quote on IT Industry by Pradyumn Sharma, ...
